Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online before print November 24, 2004, 10.1148/radiol.2341040508
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2341040508v1
234/1/250    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bilecen, D.
Right arrow Articles by Bongartz, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bilecen, D.
Right arrow Articles by Bongartz, G.
(Radiology 2005;234:250-255.)
© RSNA, 2004


Technical Developments

Lower Extremity: Low-Dose Contrast Agent Intraarterial MR Angiography in Patients—Initial Results1

Deniz Bilecen, MD, PhD, Anja-Carina Schulte, PhD, Hanns G. Heidecker, MD, Markus Aschwanden, MD, Rolf Huegli, MD, Kurt A. Jaeger, MD, Wladimir Ostheim-Dzerowycz, MD and Georg Bongartz, MD

1 From the Departments of Diagnostic Radiology (D.B., H.G.H., R.H., G.B.) and Angiology (M.A., K.A.J.), University of Basel, Petersgraben 4, CH-4031 Basel, Switzerland; Biozentrum, University of Basel, Switzerland (A.C.S.); and Hochrheinklinik, Bad Saeckingen, Germany (W.O.D.). Received March 17, 2004; revision requested May 25; revision received June 17; accepted June 28. Address correspondence to D.B. (e-mail: dbilecen@uhbs.ch).

Institutional review board approval and patient consent were obtained. A low-dose injection protocol for intraarterial three-dimensional (3D) gadolinium-enhanced magnetic resonance (MR) angiography was derived from femoral flow phantom studies and prospectively evaluated in patients with peripheral arterial occlusive disease (PAOD). All MR angiograms were obtained at 1.5 T with a T1-weighted gradient-echo sequence. MR angiograms of a gadolinium dilution series (0.8–200.0 mmol/L) were acquired in a femoral phantom at different flow rates. Signal-to-noise ratios (SNRs) above the 75% threshold of the measured maximum were considered optimal. The lowest optimal concentration was injected intraarterially in nine patients to obtain 3D MR angiograms of the thigh and calf station. Contrast-to-noise ratios (CNRs) were calculated for four arterial segments. The low optimal concentration of 50 mmol/L (20-mL bolus volume), about 5% of the total permissible dose, showed SNRs larger than the 75% threshold in the phantom study. In patients, this concentration led to high-spatial-resolution angiograms with mean CNRs of 70.0 ± 14.5 (± standard deviation) for the superficial femoral artery and 47.5 ± 13.4 at the infrapopliteal level. Low-dose contrast agent intraarterial 3D MR angiography showed high arterial enhancement, enabling assessment of lower extremity arteries in patients with PAOD and multiple injections—a crucial precondition for MR-guided endovascular interventions.   

© RSNA, 2004




This article has been cited by other articles:


Home page
Am. J. Roentgenol.Home page
S. Potthast, G. M. Bongartz, R. Huegli, A.-C. Schulte, J. G. Schwarz, M. Aschwanden, and D. Bilecen
Intraarterial Contrast-Enhanced MR Aortography With and Without Parallel Acquisition Technique in Patients with Peripheral Arterial Occlusive Disease
Am. J. Roentgenol., March 1, 2007; 188(3): 823 - 829.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
R. W. Huegli, M. Aschwanden, K. Scheffler, and D. Bilecen
Fluoroscopic contrast-enhanced MR angiography with a magnetization-prepared steady-state free precession technique in peripheral arterial occlusive disease.
Am. J. Roentgenol., July 1, 2006; 187(1): 242 - 247.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
R. W. Huegli, M. Aschwanden, G. Bongartz, K. Jaeger, H.-G. Heidecker, C. Thalhammer, A.-C. Schulte, C. Hashagen, A. L. Jacob, and D. Bilecen
Intraarterial MR Angiography and DSA in Patients with Peripheral Arterial Occlusive Disease: Prospective Comparison
Radiology, June 1, 2006; 239(3): 901 - 908.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
A.-C. Schulte, G. Bongartz, R. Huegli, M. Aschwanden, K. A. Jaeger, W. Ostheim-Dzerowycz, A. L. Jacob, and D. Bilecen
Intraarterial Versus IV Gadolinium Injections for MR Angiography: Quantitative and Qualitative Assessment of the Infrainguinal Arteries
Am. J. Roentgenol., September 1, 2005; 185(3): 735 - 740.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
RADIOLOGY RADIOGRAPHICS RSNA JOURNALS ONLINE
Copyright © 2005 by the Radiological Society of North America.